Cidara Therapeutics Math Transform Inverse Tangent Over Price Movement
| CDTXDelisted Stock | USD 221.38 0.06 0.03% |
| Symbol |
Transformation |
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
Cidara Therapeutics Technical Analysis Modules
Most technical analysis of Cidara Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Cidara from various momentum indicators to cycle indicators. When you analyze Cidara charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Stock Overview, Methodology & Data Sources
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. Cidara Therapeutics, Inc. was incorporated in 2012 and is based in San Diego, California. Cidara Thera operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 89 people. Downside history and drawdown behavior provide context for risk expectations in Cidara Therapeutics. Past price movements indicate comparatively limited downside dispersion. Cidara Therapeutics has a market cap of 6.96 B, ROE of -68.7%.
Methodology
Unless otherwise specified, financial data for Cidara Therapeutics is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Cidara (USA Stocks:CDTX) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: The dataset for Cidara Therapeutics incorporates public filings and market reference sources and official institutional disclosures, including U.S. Securities and Exchange Commission (SEC) via EDGAR. Some inputs may not update instantaneously. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Cidara Therapeutics may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
This content is curated and reviewed by:
Raphi Shpitalnik - Junior Member of Macroaxis Editorial BoardLearn to be your own money manager
Portfolio analytics tied to Cidara Therapeutics help investors review performance in context instead of judging the holding in isolation. This is most helpful when investors want a consistent framework for balancing conviction with risk control.
Did you try this?
Run Economic Indicators Now
Economic IndicatorsTop statistical indicators that provide insights into how an economy is performing |
| All Next | Launch Module |
Cidara Therapeutics pair trading
Pair analysis around Cidara Therapeutics matters because it can turn one security idea into a more market-neutral structure. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.
Cidara Therapeutics Pair Trading
Cidara Therapeutics Pair Trading Analysis
The information in the correlation table below can inform Cidara Therapeutics tax-loss harvesting decisions, showing which instruments historically move in lockstep with Cidara Therapeutics and can serve as viable temporary replacements.
Negative correlation assets provide natural hedges against Cidara Therapeutics positions. When Cidara Therapeutics's value declines, a negatively correlated instrument tends to rise, partially offsetting portfolio losses.
Correlation analysis and pair evaluation for Cidara Therapeutics can support hedging context. The context can be applied within sectors, industries, or broader universes.Cidara Therapeutics has a market cap of 6.96 B, ROE of -68.7%. See Trending Equities for portfolio-level analysis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.Cidara Therapeutics currently shows ROE of -68.7%, market cap of 6.96 Billion. Cidara Therapeutics analysis should be paired with portfolio risk and diversification tools before adjusting allocations. For Cidara Therapeutics, the analytical tools below add portfolio-level context that single-security review alone cannot provide. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Consideration for investing in Cidara Stock
Cidara Therapeutics historical volatility may reflect structural changes following delisting.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |